Results 191 to 200 of about 5,752,243 (395)
European Journal of Heart Failure, EarlyView.The value of uACR. CKD, chronic kidney disease; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; uACR, urine albumin‐to‐creatinine ratio. Abstract The high disease burden and bidirectional relationship of chronic kidney disease (CKD), heart failure (HF) and other cardiovascular disease (CVD) necessitate the need for early ...
Biykem Bozkurt +2 more
wiley +1 more source
I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients
Blood Cancer Journal, 2022 Sarvarinder K. Gill +9 more
doaj +1 more source
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
The Lancet Oncology, 2014 S. Rajkumar +33 more
semanticscholar +1 more source
European Journal of Heart Failure, EarlyView.Cancer patients presenting to the emergency department ED with dyspnoea. Among 2153 patients presenting to the ED with dyspnea, 473 (22.0%) had an active or past cancer. Acute heart failure (AHF) was the most common final diagnosis in both groups. Pneumonia and cancer‐related dyspnoea were more common in cancer patients.
Paolo Bima +20 more
wiley +1 more source
Cell Reports, 2018 Summary: The relationship between promoter proximal transcription factor-associated gene expression and super-enhancer-driven transcriptional programs are not well defined.
Mariateresa Fulciniti +12 more
doaj
Multiple Myeloma and Normal Pregnancy [PDF]
, 1966 Leonard Kosova, Steven O. Schwartz
openalex +1 more source
Multiple Myeloma Presenting as Acute Tubulointerstitial Nephritis and Normal Serum Protein Electrophoresis [PDF]
, 2012 Multiple myeloma is uncommon in individuals younger than 40 years. Renal involvement is common in this disease, but acute tubulointerstitial nephritis is very rare. In 20% of patients, only the light chain is produced and serum protein electrophoresis is
Hajigholami, A., Momeni, A., Nasri, H.
core
Exploration, EarlyView.Using celastrol as a case study, this review summarizes various target discovery strategies for natural products, including chemical proteomics, protein microarray, degradation‐based protein profiling, proteome‐wide label‐free approaches, network pharmacology, target‐based drug screening, and indirect strategies.
Yanbei Tu +5 more
wiley +1 more source
Blood Advances: Elotuzumab is a monoclonal antibody targeting signaling lymphocyte activation molecule F7 on plasma and natural killer cells, which enhances the activity of lenalidomide, pomalidomide, and bortezomib in multiple myeloma (MM). The OPTIMISMM study showed
Andrew J. Yee +22 more
doaj